Literature DB >> 10078198

Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity.

Z Wu1, E D Rosen, R Brun, S Hauser, G Adelmant, A E Troy, C McKeon, G J Darlington, B M Spiegelman.   

Abstract

Mice deficient in C/EBP alpha have defective development of adipose tissue, but the precise role of C/EBP alpha has not been defined. Fibroblasts from C/EBP alpha(-/-) mice undergo adipose differentiation through expression and activation of PPAR gamma, though several clear defects are apparent. C/EBP alpha-deficient adipocytes accumulates less lipid, and they do not induce endogenous PPAR gamma, indicating that cross-regulation between C/EBP alpha and PPAR gamma is important in maintaining the differentiated state. The cells also show a complete absence of insulin-stimulated glucose transport, secondary to reduced gene expression and tyrosine phosphorylation for the insulin receptor and IRS-1. These results define multiple roles for C/EBP alpha in adipogenesis and show that cross-regulation between PPAR gamma and C/EBP alpha is a key component of the transcriptional control of this cell lineage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10078198     DOI: 10.1016/s1097-2765(00)80306-8

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  334 in total

1.  C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.

Authors:  Evan D Rosen; Chung-Hsin Hsu; Xinzhong Wang; Shuichi Sakai; Mason W Freeman; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

Review 2.  Molecular mechanisms of adipocyte differentiation.

Authors:  Q Tong; G S Hotamisligil
Journal:  Rev Endocr Metab Disord       Date:  2001-10       Impact factor: 6.514

3.  Cooperation between C/EBPalpha TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation.

Authors:  T A Pedersen; E Kowenz-Leutz; A Leutz; C Nerlov
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

Review 4.  Lipoatrophic diabetes and other related syndromes.

Authors:  Elif Arioglu Oral
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

5.  Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone.

Authors:  Leanne Wilson-Fritch; Alison Burkart; Gregory Bell; Karen Mendelson; John Leszyk; Sarah Nicoloro; Michael Czech; Silvia Corvera
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

6.  Glut4 storage vesicles without Glut4: transcriptional regulation of insulin-dependent vesicular traffic.

Authors:  Danielle N Gross; Stephen R Farmer; Paul F Pilch
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

7.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors:  Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

8.  G0/G1 switch gene 2 has a critical role in adipocyte differentiation.

Authors:  H Choi; H Lee; T-H Kim; H J Kim; Y J Lee; S J Lee; J H Yu; D Kim; K-S Kim; S W Park; J-W Kim
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

9.  p300-dependent acetylation of activating transcription factor 5 enhances C/EBPβ transactivation of C/EBPα during 3T3-L1 differentiation.

Authors:  Yue Zhao; Ya-Dong Zhang; You-You Zhang; Shu-Wen Qian; Zhi-Chun Zhang; Shu-Fen Li; Liang Guo; Yuan Liu; Bo Wen; Qun-Ying Lei; Qi-Qun Tang; Xi Li
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

10.  Sequence analysis of bovine C/EBPδ gene and its adipogenic effects on fibroblasts.

Authors:  Hong Wang; Gong Cheng; Changzhen Fu; Hongbao Wang; Wucai Yang; Hongcheng Wang; Linsen Zan
Journal:  Mol Biol Rep       Date:  2013-11-09       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.